About cCHID
Seamless and comprehensive support from basic research through clinical trials for human immunological diseases
Infectious diseases, allergies, autoimmune diseases, inflammatory bowel diseases and cancer are diseases involving the immune system. Many of these immune-related diseases are challenging to treat and their management has become a significant social challenge.
-
For the clinical application of new drug candidates, a comprehensive support system and research infrastructure is needed, from basic research to clinical trials.
-
A system providing barrier-free access to cutting-edge technologies like single-cell analysis and data science is necessary.
-
Accessing to clinical samples is necessary for research using human samples, which is important for the clinical application of new drug candidates.
To accelerate the societal implementation of research outcomes related to immune-related diseases,
cCHID
has established as a resource platform to support.
cCHID will bring together relevant internal and external expertise and resources and address these challenges.
Key initiatives
 |
Support for bringing vaccines into practical use
|
 |
Support researchers by developing advanced analytical technology in collaboration with equipment manufacturers and establishing a university-wide system for implementation |
 |
Developing novel fields in medicine and drug discovery through quantum technologies |
 |
Strengthen the clinical trial support framework and build “Chiba University model” |